MODELING COVID19 IN INDIA (Mar 3-May 7, 2020): HOW FLAT IS FLAT, AND OTHER HARD FACTS
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
A time-series model was developed for Number of Total Infected Cases in India , using data from Mar 3 to May 7, 2020 . Two models developed in the early phases were discarded when they lost statistical validity, The third, current, model is a 3 rd -degree polynomial that has remained stable over the last 30 days (since Apr 8), with R 2 > 0.998 consistently . This model is used to forecast Total Covid cases, after cautionary discussion of triggers that would invalidate the model. The purpose of all forecasts in the study is to provide a comparator to evaluate policy initiatives to control the pandemic - the forecasts are not objectives by themselves. Actual observations less than forecasts mean successful policy interventions. Figures of Doubling Time , Fatality Rate and Recovery Rate used by authorities are questioned. Elongation of doubling rates is inherent in the model, and worthy of mention only when the time actually exceeds what the model predicts. The popular Fatality Rate and Recovery Rate metrics are shown to be illogical. The study defines two terms Ongoing Fatality Rate (OFR) , and Ongoing Recovery Rate (ORR) and determines these currently to be ~9% and ~76% respectively in India. Over time, OFR will decline to the eventual Case Fatality Rate (CFR), while ORR will eventually climb to (1-CFR). There is no statistical basis to assume eventual Indian CFR, and China’s 5.5% CFR is used as a proxy. Using these metrics, the current model forecasts by May-end, >150000 Total Infected, ~5000 Deaths and >85000 Active Cases . There is no pull-back evident in the current model in the foreseeable future, and cases continue to rise at progressively slower rates. Subject to usual caveats, the model is used to forecast till Sep 15. The study argues that Indian hospital infrastructure is reasonably ready to handle Active Cases as predicted for Sept 15 – in that sense, the curve is “flat enough”. However, the curve is NOT flat enough with respect to fatalities - nearly 100000 by Sept 15 . Setting an arbitrary limit that Total Deaths must be within 50,000 by Sept 15, the study retrofits a model that shows what the desired growth of Covid19 cases should be. It is seen that overall doubling time of 38 days is required in period June 1 to Sep 15, if deaths are to remain below 50000 .
Article activity feed
- 
      SciScore for 10.1101/2020.05.11.20097865: (What is this?) Please note, not all rigor criteria are appropriate for all manuscripts. Table 1: Rigor Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources No key resources detected. Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog). 
 Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced. Results from Barzooka: We did not find any issues relating to the usage of bar … SciScore for 10.1101/2020.05.11.20097865: (What is this?) Please note, not all rigor criteria are appropriate for all manuscripts. Table 1: Rigor Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources No key resources detected. Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog). 
 Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced. Results from Barzooka: We did not find any issues relating to the usage of bar graphs. Results from JetFighter: We did not find any issues relating to colormaps. 
 Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
 
- 
    
